Русский

Pharmaceutical Industry Information Portal

HomeTagsAstraZeneca

All posts by tag

AstraZeneca

AstrazenecaAstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. – Read More 

World Pharma News

New investments in the innovative biotechnology company “Target Medicals”

Techno -
RDIF, AstraZeneca and Unicorn Capital Partners invest in Target Medicals, developing aldosterone synthase inhibitor for the treatment of resistant arterial hypertension. The Russian Direct Investment...
World Pharma News

Russia approves AstraZeneca’s drug for coronavirus prophylaxis

Techno -
The Russian Ministry of Health approved circulation of Evusheld, a COVID-19 prophylaxis drug by AstraZeneca, on the territory of the country, according to the...
World Pharma News

AstraZeneca and Neurimmune sign exclusive global collaboration to develop and commercialise NI006

Techno -
Alexion, AstraZeneca’s Rare Disease group, has entered into an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal...
World Pharma News

The combination of AstraZeneca and Sputnik Light vaccines in Azerbaijan shows strong neutralizing antibodies growth

Techno -
R-Pharm Group, the Russian Direct Investment Fund (RDIF) and AstraZeneca announce preliminary virus neutralizing activity results of combined use of the AstraZeneca vaccine (developed...
Discovery and Development

A combination between AstraZeneca and Sputnik Light demonstrates high immunogenicity profile

Techno -
Clinical trials in Azerbaijan began in February 2021. To date 64 volunteers have been vaccinated, the enrollment of volunteers is ongoing.
Discovery and Development

Combination of the Sputnik Light with others vaccines demonstrates high safety profile

Techno -
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.
123Page 2 of 3
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories